| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000045862 |
| Receipt No. | R000051284 |
| Scientific Title | Safety of the robot-assisted laparoscopic gastrectomy |
| Date of disclosure of the study information | 2021/10/25 |
| Last modified on | 2021/10/25 (Ver. 1) |
| Basic information | ||
| Public title | Safety of the robot-assisted laparoscopic gastrectomy
|
|
| Acronym | Da Vinci-gastrectomy | |
| Scientific Title | Safety of the robot-assisted laparoscopic gastrectomy | |
| Scientific Title:Acronym | Da Vinci-gastrectomy | |
| Region |
|
|
| Condition | ||
| Condition | Stage I-II gastric cancer
|
|
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Assess the safety of robot-assisted gastrectomy |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Overall adverse event occurrence rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Robot-assisted gastrectomy (distal or total gastrectomy) will be performed on cStage I-II gastric cancer patients. | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Gastric cancer patients
(2) cStage I-II (3) ECOG Performance Status Scale: 0-1 (4) Patient age of 20 year-old or over (5) Both male and female (6) Written informed consent is obtained |
|||
| Key exclusion criteria | (1) With multiple primary cancer
(2) Uncontrollable mental disorder (3) Long-term steroid therapy (4) Severe renal disfunction (5) Uncontrollable hypertension or diabetes (6) Pregnant case (7) Other conditions judged ineligible by physician |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Department of Surgery | ||||||
| Zip code | 980-8574 | ||||||
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan | ||||||
| TEL | 022-717-7205 | ||||||
| hirofumi-i@surg.med.tohoku.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Department of Surgery | ||||||
| Zip code | 980-8574 | ||||||
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan | ||||||
| TEL | 022-717-7205 | ||||||
| Homepage URL | |||||||
| hirofumi-i@surg.med.tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tohoku University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tohoku University Hospital |
| Address | 1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan |
| Tel | 022-717-7205 |
| hospital-koe@grp.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051284 |